The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report - Mu, Chunyang; Shen, Junyi; Zhu, Xinrui; Peng, Wei; Zhang, Xiaoyun; Wen, Tianfu (Frontiers in oncology, 2023)
Keywords: combination therapy; lenvatinib; Oncology; programmed death-1 antibody; recurrent hepatocellular carcinoma; trans-arterial chemoembolization; recurrent hepatocellular carcinoma; combination therapy; lenvatinib; trans-arterial chemoembolization; programmed death-1 antibody